Clinical trial
Comparative Study of Dapagliflozin Versus Glibenclamide Effect on Endothelial Function of Coronary Artery Disease Patients
NCT02919345 is registered in ClinicalTrials.gov with University of Campinas, Brazil as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparative Study of Dapagliflozin Versus Glibenclamide Effect on Endothelial Function of Coronary Artery Disease Patients
- Lead sponsor
- University of Campinas, Brazil
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- January 31, 2017
- Completion date
- March 31, 2019
- Enrollment
- 98 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.